Safety and Efficacy of Varicella Zoster Immune Globulin (Human) VariZIG in Patients at Risk of Varicella Infection
Clinical trial NCT00338442 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00338442
- Sponsor
- Cangene Corporation
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2006-02-01
- Primary completion
- 2009-12-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.